Reply: Urinary Excretion of MicroRNA-126 Is a Biomarker for Hemangioma Proliferation.
作者信息
Gordillo Gayle M
机构信息
915 Olentangy River Road, Suite 2100, Columbus, Ohio 43212,
出版信息
Plast Reconstr Surg. 2018 Feb;141(2):320e. doi: 10.1097/PRS.0000000000004090.
Abstract
摘要
相似文献
1
Reply: Urinary Excretion of MicroRNA-126 Is a Biomarker for Hemangioma Proliferation.回复：微小RNA - 126的尿排泄是血管瘤增殖的生物标志物。
Plast Reconstr Surg. 2018 Feb;141(2):320e. doi: 10.1097/PRS.0000000000004090.
2
Urinary Excretion of MicroRNA-126 Is a Biomarker for Hemangioma Proliferation.微小RNA-126的尿液排泄是血管瘤增殖的生物标志物。
Plast Reconstr Surg. 2018 Feb;141(2):319e-320e. doi: 10.1097/PRS.0000000000004078.
3
microRNA-143 acts as a suppressor of hemangioma growth by targeting Bcl-2.微小RNA-143通过靶向Bcl-2发挥抑制血管瘤生长的作用。
Gene. 2017 Sep 10;628:211-217. doi: 10.1016/j.gene.2017.07.046. Epub 2017 Jul 14.
4
Silencing microRNA-210 in Hypoxia-Induced HUVEC-Derived Extracellular Vesicles Inhibits Hemangioma.缺氧诱导的 HUVEC 衍生细胞外囊泡中 miR-210 的沉默抑制血管瘤。
Cerebrovasc Dis. 2020;49(5):462-473. doi: 10.1159/000508302. Epub 2020 Sep 2.
5
Upregulation of AKT1 and downregulation of AKT3 caused by dysregulation of microRNAs contributes to pathogenesis of hemangioma by promoting proliferation of endothelial cells.微小 RNA 失调引起的 AKT1 上调和 AKT3 下调导致内皮细胞增殖促进，有助于血管瘤的发病机制。
J Cell Physiol. 2019 Nov;234(11):21342-21351. doi: 10.1002/jcp.28741. Epub 2019 May 9.
6
MicroRNA Microarray Profiling in Infantile Hemangiomas.婴儿血管瘤中的微小RNA微阵列分析
Eplasty. 2019 Apr 16;19:e13. eCollection 2019.
7
Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis.尿液和血液中的微小RNA-126和-770是糖尿病肾病潜在的非侵入性生物标志物候选物：一项荟萃分析。
Cell Physiol Biochem. 2018;46(4):1331-1340. doi: 10.1159/000489148. Epub 2018 Apr 18.
8
Prognostic Circulating MicroRNA Biomarkers in Early-Stage Non-Small Cell Lung Cancer: A Role for miR-150.早期非小细胞肺癌的预后循环 microRNA 生物标志物：miR-150 的作用。
Clin Pharmacol Ther. 2018 Jun;103(6):968-970. doi: 10.1002/cpt.972. Epub 2017 Dec 29.
9
Long noncoding RNA LINC00342 promotes growth of infantile hemangioma by sponging miR-3619-5p from HDGF.长链非编码 RNA LINC00342 通过海绵吸附 HDGF 的 miR-3619-5p 促进婴幼儿血管瘤的生长。
Am J Physiol Heart Circ Physiol. 2019 Oct 1;317(4):H830-H839. doi: 10.1152/ajpheart.00188.2019. Epub 2019 Aug 30.
10
miR-199a-5p inhibits proliferation and induces apoptosis in hemangioma cells through targeting HIF1A.miR-199a-5p 通过靶向 HIF1A 抑制血管瘤细胞的增殖并诱导其凋亡。
Int J Immunopathol Pharmacol. 2018 Jan-Dec;31:394632017749357. doi: 10.1177/0394632017749357. Epub 2017 Dec 22.
本文引用的文献
1
Urinary Excretion of MicroRNA-126 Is a Biomarker for Hemangioma Proliferation.微小RNA-126的尿排泄是血管瘤增殖的生物标志物。
Plast Reconstr Surg. 2017 Jun;139(6):1277e-1284e. doi: 10.1097/PRS.0000000000003349.
2
Nox-4-dependent nuclear H2O2 drives DNA oxidation resulting in 8-OHdG as urinary biomarker and hemangioendothelioma formation.Nox-4 依赖性核 H2O2 驱动 DNA 氧化，导致 8-OHdG 作为尿生物标志物和血管内皮细胞瘤形成。
Antioxid Redox Signal. 2010 Apr 15;12(8):933-43. doi: 10.1089/ars.2009.2917.
3
Growth characteristics of infantile hemangiomas: implications for management.婴儿血管瘤的生长特征：对治疗的启示
Pediatrics. 2008 Aug;122(2):360-7. doi: 10.1542/peds.2007-2767.
4
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.生物标志物与替代终点：首选定义及概念框架
Clin Pharmacol Ther. 2001 Mar;69(3):89-95. doi: 10.1067/mcp.2001.113989.
Zotero 插件